Skip to main content

Table 2 Univariable and multivariable analysis for factors predicting AOIs within 90 days of initial HIV care

From: AIDS-related opportunistic illnesses and early initiation of HIV care remain critical in the contemporary HAART era: a retrospective cohort study in Taiwan

  Univariable analysis Multivariable analysisa
OR (95% CI) P AOR (95% CI) P
Age, per 10-year increase 2.35 (2.02–2.74) < 0.001 1.95 (1.58–2.41) < 0.001
Male sex 0.66 (0.26–1.71) 0.39 2.38 (0.62–9.16) 0.21
HIV transmission route
 Homosexual 1.00 (Reference)   1.00 (Reference)  
 Heterosexual 3.61 (2.48–5.26) < 0.001 1.83 (1.05–3.19) 0.034
 Bisexual 2.55 (1.51–4.31) < 0.001 1.95 (0.96–3.94) 0.065
 IDU 3.99 (1.37–11.66) 0.011 1.57 (0.35–6.96) 0.56
 Unknown 7.10 (1.57–32.02) 0.011 1.39 (0.21–9.17) 0.73
Period
 Period 1 (2010–2011) 1.00 (Reference)   1.00 (Reference)  
 Period 2 (2012–2013) 0.87 (0.63–1.21) 0.41 0.87 (0.56–1.34) 0.52
 Period 3 (2014–2015) 0.80 (0.56–1.13) 0.20 0.92 (0.58–1.46) 0.72
Chronic kidney disease 4.03 (0.81–20.1) 0.089 0.84 (0.77–9.17) 0.89
Diabetes mellitus 3.78 (1.65–8.68) 0.002 1.02 (0.29–3.57) 0.97
Subgroup of CD4 cell count at presentation
 CD4 count ≥500 cells/μL 1.00 (Reference)   1.00 (Reference)  
 CD4 count 200–499 cells/μL 1.05 (0.29–3.78) 0.94 0.91 (0.25–3.33) 0.88
 CD4 count < 200 cells/μL 49.54 (15.60–157.40) < 0.001 40.84 (12.59–132.49) < 0.001
HBsAg seropositivity 2.09 (1.38–3.16) 0.001 1.32 (0.76–2.29) 0.33
HCV seropositivity 2.30 (1.20–4.39) 0.012 2.07 (0.81–5.34) 0.13
  1. Abbreviations: AIDS acquired immune deficiency syndrome, AOI AIDS-defining opportunistic illness, AOR adjusted odd ratio, CI confidence interval, HBsAg hepatitis B surface antigen, HCV hepatitis C virus, OR odd ratio, IDU intravenous drug users
  2. aAll variables in the univariate analysis were selected for subsequent multivariate analysis